Physicians' Desk Reference: PDR, Volume 40Edward R. Barnhart |
From inside the book
Results 1-3 of 81
Page 560
... toxicity exhibited by fluoro- uracil . Patients should be carefully supervised since it must be recognized that therapeutic response is unlikely to occur without some evidence of toxicity . Patients should be advised of expected toxic ...
... toxicity exhibited by fluoro- uracil . Patients should be carefully supervised since it must be recognized that therapeutic response is unlikely to occur without some evidence of toxicity . Patients should be advised of expected toxic ...
Page 1328
... toxic- ity , and serum theophylline levels are recommended to as- sure maximal benefit without excessive risk ; incidence of toxicity increases at levels greater than 20 mcg theophyl- line / ml . Morphine , curare , and stilbamidine ...
... toxic- ity , and serum theophylline levels are recommended to as- sure maximal benefit without excessive risk ; incidence of toxicity increases at levels greater than 20 mcg theophyl- line / ml . Morphine , curare , and stilbamidine ...
Page 1440
... toxic- ity . Determination of serum theophylline levels is recom- mended to assure maximum therapeutic benefit without excessive risk . The incidence of toxicity increases at serum levels greater than 20 mcg / ml . Optimum therapeutic ...
... toxic- ity . Determination of serum theophylline levels is recom- mended to assure maximum therapeutic benefit without excessive risk . The incidence of toxicity increases at serum levels greater than 20 mcg / ml . Optimum therapeutic ...
Contents
Product Category | 420 |
BISMUTH PREPARATIONS | 426 |
DIAGNOSTICS | 437 |
Copyright | |
3 other sections not shown
Common terms and phrases
Abbott acid acute adults Adverse Reactions agents alcohol amoxicillin anesthesia anesthetic Ayerst barbiturates bleeding blood pressure bottles of 100 breast cancer Capsules cardiac cause caution Chewable chloride Codeine concentration Contraindications Cream decrease depression deserpidine discontinued disease Dosage and Administration dose drug effects epinephrine erythromycin estrogens excreted FD&C Filmtab fluid gastrointestinal Guaifenesin heparin hepatic hydrochloride Hydrochlorothiazide hypersensitivity hypertension hypokalemia hypotension impaired increased INDERAL indicated infusion Injection intravenous Laboratories Lederle lidocaine Liquid liver local anesthetic Merck Sharp metabolized nausea occur Ointment oral contraceptives overdosage Parke-Davis patients receiving Pediatric Pharmaceutical phenobarbital phosphate plasma potassium potassium chloride potential Precautions pregnancy Pregnancy Category PREMARIN propranolol Pseudoephedrine recommended renal reported respiratory risk Roche serum Sharp & Dohme Shown smaller smaller than actual sodium solution sterile sulfamethizole sulfate symptoms Syrup tablet contains Tablets Schein therapy Thiazides tion toxicity treatment urine usually vaginal vial vitamin vomiting Warnings women Wyeth Xylocaine